EPS Bio Technology Corp. Statistics
EPS Bio Technology Corp. (4183) Stock Statistics & Valuation Metrics
Total Valuation
EPS Bio Technology Corp. has a market cap or net worth of TWD 342.72M. The enterprise value is TWD 424.76M.
- Market Cap
- TWD 342.72M
- Enterprise Value
- TWD 424.76M
Share Statistics
EPS Bio Technology Corp. has 23,800,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 23,800,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
EPS Bio Technology Corp.’s return on equity (ROE) is -0.03 and return on invested capital (ROIC) is -1.74%.
- Return on Equity (ROE)
- -0.03
- Return on Assets (ROA)
- -0.01
- Return on Invested Capital (ROIC)
- -1.74%
- Return on Capital Employed (ROCE)
- -0.02
- Revenue Per Employee
- 4.63M
- Profits Per Employee
- -72.83K
- Employee Count
- 108
- Asset Turnover
- 0.94
- Inventory Turnover
- 5.70
Valuation Ratios
The current PE Ratio of EPS Bio Technology Corp. is -34.16. EPS Bio Technology Corp.’s PEG ratio is 0.13.
- PE Ratio
- -34.16
- PS Ratio
- 0.82
- PB Ratio
- 1.28
- Price to FCF
- -41.34
- Price to Operating Cash Flow
- 35.24
- PEG Ratio
- 0.13
Income Statement
In the last 12 months, EPS Bio Technology Corp. had revenue of 499.70M and earned -7.87M in profits. Earnings per share was -0.33.
- Revenue
- 499.70M
- Gross Profit
- 81.93M
- Operating Income
- -9.10M
- Pretax Income
- -9.67M
- Net Income
- -7.87M
- EBITDA
- 6.29M
- Earnings Per Share (EPS)
- -0.33
Cash Flow
In the last 12 months, operating cash flow was 9.72M and capital expenditures -18.02M, giving a free cash flow of -8.29M billion.
- Operating Cash Flow
- 9.72M
- Free Cash Flow
- -8.29M
- Free Cash Flow per Share
- -0.35
Dividends & Yields
EPS Bio Technology Corp. pays an annual dividend of ―, resulting in a dividend yield of 4.65%
- Dividend Per Share
- ―
- Dividend Yield
- 4.65%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -2.42%
- Earnings Yield
- -2.87%
Stock Price Statistics
- Beta
- 0.27
- 52-Week Price Change
- -19.78%
- 50-Day Moving Average
- 14.10
- 200-Day Moving Average
- 14.59
- Relative Strength Index (RSI)
- 52.55
- Average Volume (3m)
- 8,446
Important Dates
EPS Bio Technology Corp. upcoming earnings date is Nov 11, 2026, TBA (Not Confirmed).
- Last Earnings Date
- May 06, 2026
- Next Earnings Date
- Nov 11, 2026
- Ex-Dividend Date
- ―
Financial Position
EPS Bio Technology Corp. as a current ratio of 2.30, with Debt / Equity ratio of 50.07%
- Current Ratio
- 2.30
- Quick Ratio
- 1.83
- Debt to Market Cap
- 0.13
- Net Debt to EBITDA
- 2.81
- Interest Coverage Ratio
- -4.80
Taxes
In the past 12 months, EPS Bio Technology Corp. has paid -1.80M in taxes.
- Income Tax
- -1.80M
- Effective Tax Rate
- 0.19
Enterprise Valuation
EPS Bio Technology Corp. EV to EBITDA ratio is 169.61, with an EV/FCF ratio of -42.11.
- EV to Sales
- 0.83
- EV to EBITDA
- 169.61
- EV to Free Cash Flow
- -42.11
- EV to Operating Cash Flow
- 35.89
Balance Sheet
EPS Bio Technology Corp. has TWD 131.56M in cash and marketable securities with TWD 137.90M in debt, giving a net cash position of -TWD 6.34M billion.
- Cash & Marketable Securities
- TWD 131.56M
- Total Debt
- TWD 137.90M
- Net Cash
- -TWD 6.34M
- Net Cash Per Share
- -TWD 0.27
- Tangible Book Value Per Share
- TWD 11.07
Margins
Gross margin is 15.23%, with operating margin of -5.37%, and net profit margin of -2.35%.
- Gross Margin
- 15.23%
- Operating Margin
- -5.37%
- Pretax Margin
- -1.83%
- Net Profit Margin
- -2.35%
- EBITDA Margin
- 0.49%
- EBIT Margin
- -3.50%
Analyst Forecast
The average price target for EPS Bio Technology Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -10.81%
- EPS Growth Forecast
- 30.88%
